MedPage Today on MSN

Blood Test May Be a 'Viable Alternative' in Liver Cancer Surveillance

This multi-target blood test "offers the potential for improved patient outcomes through earlier HCC detection," John said ...
MedPage Today on MSN

Year in Review: Alzheimer's Disease

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...
Healio

Blood test shows ‘fantastic’ predictive value for preeclampsia in sickle cell disease

Women with sickle cell disease have a significantly higher likelihood of developing preeclampsia than the general population, but a blood test could identify which patients have the greatest risk.A ...

Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test

Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.

New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

DecisionDx-Melanoma continues to demonstrate strong performance in helping physicians make more informed, risk-aligned ...
The Lancet

Artificial intelligence in women’s cancers: innovation and challenges in clinical translation

Artificial intelligence (AI) is set to transform the care of women with cancer. From early detection via digital phenotyping ...
Targeted Oncology

FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma

The FDA approves a new diagnostic tool enhancing precision treatment for advanced endometrial carcinoma, improving patient ...
Healio

Q&A: Metastatic cancer assay for ‘getting people answers’

In August, Plus Therapeutics announced the launch of the CNSide diagnostic platform, a proprietary, highly sensitive, ...

Castle Biosciences, Inc.: New Data Confirms Performance of DecisionDx-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating ...
Study Finds on MSN

Is 13% Body Fat The Stamina Tipping Point For Soccer Players?

In this study of 52 Brazilian pros, players with 13% body fat or higher covered less distance on an endurance shuttle run ...

Natera, Inc. (NTRA) Presents at Jefferies London Healthcare Conference 2025 Transcript

Jefferies London Healthcare Conference 2025 November 18, 2025 8:00 AM ESTCompany ParticipantsSteve Chapman - CEO & ...